(Q38063794)

28 August 2017

0 references

1 reference

title

Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis (English)

1 reference

chronic obstructive pulmonary disease

28 August 2017

1 reference

Yuji Oba

1

1 reference

28 August 2017

Nazir A Lone

series ordinal

2

1 reference

28 August 2017

language of work or name

1 reference

29 November 2012

1 reference

Therapeutic advances in respiratory disease

28 August 2017

1 reference

28 August 2017

7

1 reference

28 August 2017

1

1 reference

28 August 2017

13-24

1 reference

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

28 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Emerging pharmacotherapies for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Global burden of COPD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Pharmacoeconomic evaluation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Roflumilast with long-acting 2-agonists for COPD: influence of exacerbation history

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465812466167

21 January 2018

Identifiers

DOI

10.1177/1753465812466167

1 reference

release_akrcr24t7zdidjfogbjtbq7uia

28 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/akrcr24t7zdidjfogbjtbq7uia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference